| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
			5-fluorocytosine
				
			CAS 76095-16-4
				
			CGP 19835A
				
			FAMP
				
				
					Hearing impaired: 2% - 6% Fe(III
				
			Gd-DTPA
				
			Ge-132
				
			K779
				
				
					DeafnessHearing impaired: postmarketing L-Dmp
				
			Octreotide
				
				
					DeafnessHearing impairedPGE2
				
			Photofrin II
				
			T-A2-3
				
			UDCA
				
			Vancocine
				
				
					DeafnessHearing impaired: postmarketing acamprosate
				
			acitretin
				
			amikacin
				
				
					High frequency deafnessHearing impairedamphotericin B
				
				
					DeafnessHearing impairedanthracycline
				
			aripiprazole
				
				
					DeafnessHearing impairedaspirin
				
			atorvastatin
				
			azithromycin
				
				
					Deafness: postmarketing Hearing impaired: postmarketing, 0.4% - 1.1% betaxolol
				
			bexarotene
				
			boceprevir
				
				
					Deafness: uncommon Hearing impaired: uncommon bortezomib
				
				
					DeafnessHearing impaired: 1% bupropion
				
			butorphanol
				
			cabozantinib
				
			caffeine
				
			capecitabine
				
				
					DeafnessHearing impairedcapreomycin
				
			carbamazepine
				
				
					Hearing impaired: very rare carboplatin
				
			celecoxib
				
				
					DeafnessHearing impairedcetirizine
				
			cevimeline
				
			chlorhexidine gluconate
				
			cidofovir
				
				
					Hearing impaired: postmarketing ciprofloxacin
				
				
					Hearing impaired: very rare, postmarketing, rare, uncommon cisplatin
				
				
					DeafnessHigh frequency deafnessHearing impairedcitalopram
				
			clarithromycin
				
				
					Deafness: postmarketing Hearing impaired: postmarketing clofarabine
				
			clomiphene citrate
				
			clomipramine
				
			clopidogrel
				
				
					Hearing impaired: postmarketing copolymer 1
				
			cyclophosphamide
				
				
					Deafness: postmarketing Hearing impaired: postmarketing cytarabine
				
				
					Deafness: 3% Hearing impaired: 5.84% - 18.2% deferasirox
				
				
					High frequency deafnessHearing impaired: uncommon deprenyl
				
			diclofenac
				
				
					Hearing impaired: very rare diflunisal
				
				
					Hearing impaired: postmarketing docetaxel
				
			doxazosin
				
			doxepin
				
			erythromycin
				
			erythromycin stearate
				
			eslicarbazepine acetate
				
			estradiol
				
			ethacrynic acid
				
			etodolac
				
				
					Deafness: postmarketing Hearing impairedfebuxostat
				
			flecainide
				
			fluconazole
				
			fludarabine
				
				
					Hearing impaired: 2% - 6% flumazenil
				
			fluoxetine
				
			flurbiprofen
				
			fluvoxamine
				
				
					Deafness: rare, infrequent fosfomycin
				
				
					Hearing impaired: postmarketing fosfomycin trometamol
				
				
					Hearing impaired: postmarketing fosphenytoin
				
				
					Deafness: infrequent, 0% - 2.2% furosemide
				
				
					DeafnessHearing impairedgabapentin
				
				
					Deafness: infrequent Hearing impaired: infrequent gadobenate dimeglumine
				
			gadopentetate
				
				
					Hearing impaired: postmarketing ganciclovir
				
			gemcitabine
				
			gentamicin
				
			glibenclamide
				
			gliclazide
				
			hydrocodone
				
			hydroxychloroquine
				
			ibandronate
				
			ibuprofen
				
			ifosfamide
				
				
					Deafness: postmarketing Hearing impaired: postmarketing imatinib
				
				
					Hearing impaired: uncommon indomethacin
				
			iodixanol
				
			iopamidol
				
			itraconazole
				
				
					Hearing impaired: postmarketing, 3.3% kanamycin
				
			ketoprofen
				
			ketorolac
				
			ketorolac tromethamine
				
				
					DeafnessHearing impaired: postmarketing lamivudine
				
			lamotrigine
				
			lansoprazole
				
			lenalidomide
				
				
					Deafness: postmarketing Hearing impaired: postmarketing maraviroc
				
			mefenamic acid
				
			mefloquine
				
				
					Hearing impaired: postmarketing memantine
				
			metoprolol
				
				
					Deafness: very rare Hearing impaired: very rare mirtazapine
				
			misoprostol
				
			monomycin
				
			moxifloxacin
				
				
					Deafness: postmarketing Hearing impaired: postmarketing mycophenolate mofetil
				
			mycophenolic acid
				
			naproxen
				
				
					Hearing impaired: postmarketing nefazodone
				
			nilotinib
				
			norfloxacin
				
				
					Hearing impaired: postmarketing ofloxacin
				
				
					Hearing impaired: postmarketing olanzapine
				
			oxaliplatin
				
				
					Deafness: postmarketing, rare oxaprozin
				
			paclitaxel
				
				
					Hearing impaired: very rare, postmarketing pantoprazole
				
			paroxetine
				
			pegaptanib
				
				
					DeafnessHearing impairedpegaptanib sodium
				
			pentostatin
				
			pergolide
				
			phenylbutyric acid
				
			phenytoin
				
				
					Deafness: infrequent, 0% - 2.2% pilocarpine
				
			piroxicam
				
				
					DeafnessHearing impairedposaconazole
				
			pramipexole
				
				
					DeafnessHearing impairedpravastatin
				
			pregabalin
				
			procarbazine
				
			propafenone
				
			quetiapine
				
			quinidine
				
				
					DeafnessHigh frequency deafnessHearing impairedrabeprazole
				
			ramipril
				
			ramiprilat
				
			rapamycin
				
			rasagiline
				
			reserpine
				
			retinoic acid
				
				
					Hearing impaired: postmarketing Deafness: postmarketing ribavirin
				
				
					Hearing impaired: postmarketing, common riluzole
				
			risperidone
				
				
					DeafnessHearing impairedritonavir
				
			rivastigmine
				
			rizatriptan
				
			ropinirole
				
			roxithromycin
				
				
					DeafnessHearing impairedsalicylate
				
			salmon calcitonin acetate
				
				
					Hearing impaired: postmarketing salsalate
				
			saquinavir
				
			sildenafil
				
				
					Deafness: postmarketing, rare Hearing impairedsitaxsentan
				
			streptomycin
				
			sulfasalazine
				
			sumatriptan
				
				
					Deafness: postmarketing Hearing impairedtacrolimus
				
				
					Deafness: postmarketing Hearing impaired: very rare, postmarketing, uncommon tadalafil
				
			telavancin
				
			temozolomide
				
				
					Deafness: uncommon Hearing impaired: common, 1% - 4% terbinafine
				
				
					Hearing impaired: postmarketing thalidomide
				
				
					Deafness: postmarketing Hearing impaired: postmarketing thiotepa
				
			tiagabine
				
			tizanidine
				
				
					Deafness: infrequent, frequent tobramycin
				
				
					DeafnessHigh frequency deafness: common Hearing impaired: postmarketing, common topiramate
				
				
					DeafnessHearing impaired: 1% - 2% tramadol
				
			trazodone
				
				
					Hearing impaired: infrequent triazolam
				
			v 1784
				
				
					Deafness: postmarketing Hearing impaired: uncommon valganciclovir
				
			valproate
				
				
					DeafnessHearing impaired: postmarketing varenicline
				
			venlafaxine
				
			vigabatrin
				
			vinblastine
				
			vincristine
				
			vinorelbine
				
				
					Hearing impaired: postmarketing, 4% - 18% voriconazole
				
				
					DeafnessHearing impaired: rare zalcitabine
				
			zaleplon
				
			zidovudine
				
				
					Hearing impaired: postmarketing zidovudine/lamivudine
				
			zonisamide
				
			 |